Resources
Several drug companies are developing treatments for Non-alcoholic Steatohepatitis (NASH). We recently surveyed US physicians to find out how they are treating patients and comorbid conditions—and what they would like to see in a regimen.
In this on-demand webinar we hear Molly Simpson, InCrowd’s Director for Client Engagement, discuss the key findings.
Watch now!
What does good look like? If you're a pharma market researcher or marketer, you've probably come to rely on industry benchmarks to judge success and guide your team. But have you ever stopped to think about those benchmarks? How should they be calculated? Are you...
Every year we ask our physicians their views on the future of the healthcare industry. With so much disruption from COVID-19, this year’s global healthcare predictions will provide a unique window into the minds of those professionals perhaps most tested by 2020 and...
Molly Simpson, InCrowd Director of Client Engagement, and Christine Dworkin, InCrowd Senior Director of Client Services and Head of Tracking, share findings on the Impact of COVID-19 on Diabetes Patients. In this webinar Ms. Simpson will review recent InCrowd data...